Pharma companies must adapt to keep pace with AI developments, say experts
Pharmaceutical Technology
OCTOBER 25, 2024
At the Outsourcing in Clinical Trials Conference, key opinion leaders shared predictions for workflow changes due to AI.
This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Pharmaceutical Technology
OCTOBER 25, 2024
At the Outsourcing in Clinical Trials Conference, key opinion leaders shared predictions for workflow changes due to AI.
Pharmaceutical Technology
OCTOBER 28, 2022
Drug discovery and development is an incredibly expensive and time-consuming process, taking between 12 and 18 years, and costing on average between $2 billion and $3 billion. Robots can improve drug discovery and development. Lab-specific industrial co-bots can carry out both complex and repetitive tasks such as liquid handling.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Patent Watch
APRIL 8, 2025
"5 Key Considerations for Valuing Pharma Companies As the pharmaceutical industry continues to evolve, accurately valuing pharma companies has become increasingly complex. Patent Portfolio Strength : A strong patent portfolio can significantly impact a company's valuation.
AuroBlog - Aurous Healthcare Clinical Trials blog
AUGUST 3, 2023
The Institute is now looking for partners in pharma companies to pursue further clinical development of the findings. When the compound was tested […]
Pharmaceutical Technology
OCTOBER 26, 2023
Experts discuss how pharma companies need to consider patient centricity earlier in their development plans.
World of DTC Marketing
AUGUST 27, 2020
So far this year he has received well over $200,000 from just about every pharma company in the U.S. It’s well known that Mitch has argued against any pharma pricing reform so obviously money does buy politicians. Pharma companies have argued that they need profit to develop new drugs but that’s a canard.
AuroBlog - Aurous Healthcare Clinical Trials blog
APRIL 11, 2023
The pharma companies’ thrust on R&D to develop better medicines and the demand in hospitals for advanced medical technologies driven by artificial intelligence, remote patient monitoring and wearables are transforming patient care.
Pharmaceutical Technology
JULY 17, 2024
As US China trade relations are set to be impacted by the BIOSECURE Act, pharma companies exploring CDMOs outside China may need to contend with increased drug development and manufacturing costs.
Camargo
NOVEMBER 11, 2020
Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. Still, navigating such patent issues during drug development can be difficult, and Camargo can assist in finding a safe course. Ken Phelps.
Bio Pharma Dive
AUGUST 26, 2022
The pharma company terminated a collaboration that could’ve netted the biotech about $350 million. It’s the latest in a string of recent setbacks for microbiome drug developers.
AuroBlog - Aurous Healthcare Clinical Trials blog
FEBRUARY 11, 2025
Yet India needs to develop strategies to mitigate the impact of USAID funding freeze for Indian pharma companies. This is even as a large section of companies exporting to the US noted that even if foreign assistance is […]
Bio Pharma Dive
JUNE 16, 2022
The German pharma company has secured an option to acquire Trutino Biosciences, two years after inking a research collaboration with the San Diego drug developer.
World of DTC Marketing
JANUARY 11, 2022
As HCPs get more digitally savvy, pharma marketers should understand that engaging physicians through channels and time of their preference with content relevant to the individual customer. Key findings: 77% of HCPs use digital channels primarily for personal learning and development.
pharmaphorum
SEPTEMBER 22, 2021
This long-term orientation also helps family businesses align their objectives more closely with those of society and patients and maintain flexibility to invest in important areas of the business including research and development, disease awareness, diagnostics and education. About the author.
Bio Pharma Dive
DECEMBER 12, 2023
The deal signals the pharma company’s continuing interest in vaccine development and hands it a combination shot aimed at two respiratory viruses.
Pharmaceutical Technology
AUGUST 21, 2024
Pharma companies seeking to commercialise in mRNA can gain a competitive edge by partnering with expert suppliers
Pharmaceutical Technology
MARCH 6, 2023
Incannex Healthcare has collaborated with New Jersey-based pharma company Catalent for the development and manufacturing of a cGMP-grade psilocybin drug product for clinical trials and potential commercial use. The latest development follows an internal analysis of the preliminary results of the Phase II PsiGAD clinical trial.
XTalks
APRIL 2, 2024
There was also significant variability in emissions, up to five times, between pharma companies with comparable revenues. For example, Proctor & Gamble was found to emit almost five times more CO 2 e than Johnson & Johnson despite the two companies having similar revenue levels and producing similar lines of products.
pharmaphorum
APRIL 19, 2022
The first focuses on the patient journey through patient partnerships – spotting areas of challenge for specific patients and developing partnerships with different stakeholders outside Roche to improve upon the patient journey. The post The largest pharma company in Europe calls for interoperability appeared first on.
Pharmaceutical Technology
NOVEMBER 30, 2023
MSD is one of many pharma companies migrating IT applications to the cloud to transform value chains and harness new technologies.
Pharmaceutical Technology
APRIL 9, 2025
The Inflation Reduction Act (IRA) is expected to influence the clinical development strategies of pharma companies profoundly.
Pharmaceutical Technology
MARCH 16, 2023
Under the collaboration, Libera Bio and Talem Therapeutics will together develop new antibodies for use with MPN delivery. These antibodies will be provided to pharma companies for conducting late-stage development and marketing. They deliver the compounds through a cell membrane and to intracellular targets.
Fierce Pharma
MAY 6, 2024
“Our next question will come from Andrew Baum with Citi.” | Citi analyst Andrew Baum, after covering Pfizer for more than a decade, will join the Big Pharma company as chief strategy and innovation officer. In the role, he'll oversee the drugmaker's portfolio management and business development activities.
World of DTC Marketing
SEPTEMBER 7, 2022
In pharma, growth depends on new products with hefty price tags when over 80% of voters want lower costs for their prescription drugs. Biogen’s failure should be a warning to other pharma companies. Now Biogen is a shell of a company selling off assets to survive. It should be a warning to other pharma companies.
Pharmaceutical Technology
AUGUST 4, 2022
In addition to doing more to proactively support healthcare providers and patients, digital health opportunities provide a chance for pharma companies to capture (and become a trusted source of) important real-world data about patients’ behaviour and their wider wellbeing. Breaking down the opportunities.
BioPharma Reporter
NOVEMBER 20, 2024
The global CDMO has entered into several high-value manufacturing deals this year.
BioPharma Reporter
NOVEMBER 20, 2024
The global CDMO has entered into several high-value manufacturing deals this year.
Camargo
MARCH 9, 2021
Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. The FDA revealed that pharma companies are not forthcoming when they publicly disclose the reasons behind a refuse-to-file (RTF) letter from the Agency.
Pharmaceutical Technology
JUNE 14, 2023
Biologics form 51% of the current global drugs pipeline (highest stage of development as pipeline) according to GlobalData’s Drugs database (as of February 7, 2023). It is common for requirements to evolve and specifications to develop as the project unfolds.
Outsourcing Pharma
APRIL 19, 2024
revealed its Alternative Methods Advancement Project (AMAP), which it said is a strong initiative aimed at changing drug discovery and development by exploring alternatives to animal testing. Earlier this week, Charles River Laboratories International, Inc.
World of DTC Marketing
JANUARY 8, 2021
Pharma companies will make an estimated $40 billion on the global COVID-19 vaccine market this year, which will be split between Johnson & Johnson, AstraZeneca, Novavax, and others. Wall Street has been speculating for a long time on which pharma company is going to make the most from the development of a Covid-19 vaccine.
Pharmaceutical Technology
JUNE 19, 2023
Indian pharmaceutical company Laurus Labs has signed a memorandum of agreement (MoA) with the Indian Institute of Technology, Kanpur (IIT Kanpur) to bring new gene therapy products to the market. The company will also establish a GMP facility at IIT Kanpur’s Techno Park facility.
STAT News
JANUARY 6, 2023
The pharmaceutical industry has been slow to adopt a business practice that is faster, safer, and more efficient than its current way of operating; that the FDA has been encouraging the industry to implement more widely for years; and that has been used effectively in other industries for decades. I’m talking about continuous manufacturing.
Pharmaceutical Technology
APRIL 13, 2023
The company is aiming to refocus its efforts on its core therapeutic areas and current late-stage programmes such as the oral TYK2 inhibitor TAK-279, which is under development for several autoimmune disorders.
World of DTC Marketing
JANUARY 26, 2022
As HCPs get more digitally savvy, pharma marketers should understand that engaging physicians through channels and time of their preference with content relevant to the individual customer. FutureReadyHealthcare listed the following key findings: 77% of HCPs use digital channels primarily for personal learning and development.
World of DTC Marketing
APRIL 13, 2021
I reached out to three HCP marketing people at different pharma companies and asked them for their feedback on this survey. 6ix: In-House – Some pharma companies are developing in-house digital solutions to reach HCPs, but it can be costly, and getting physicians to use it can be a challenge.
Pharmaceutical Technology
NOVEMBER 3, 2023
Kronos Bio joins other pharma companies in workforce reductions, cutting 19% of its employees to support clinical development.
Pharmaceutical Technology
JUNE 15, 2023
Pharma R&D teams are solving this problem by leveraging the power of artificial intelligence (AI) in clinical trials to save time and money. Drug development is already a difficult endeavor, with the vast majority of R&D efforts failing to produce a market-worthy product. Food and Drug Administration approval.
Pharmaceutical Technology
MARCH 17, 2023
At the same time, experts are saying developers in the field need to double down on securing clinical data to allow for its continued maturation. Companies are testing the use of digital platforms along with pharmacological treatments. Securing reimbursement for digital therapeutics also continues to impede its uptake.
Pharmaceutical Technology
DECEMBER 6, 2022
HPAPIs may now represent more than 30% of the drug development pipeline. Within that figure, GlobalData estimates that around 60% of pipeline HPAPIs are developed to target oncology. In the early stages of drug development, protecting operators from unknown risks is absolutely crucial. Free Whitepaper.
Outsourcing Pharma
MAY 23, 2024
A new report from Access to Medicine Foundation gives the advice to ensure the few promising antimicrobials in development reach patients on the frontlines of drug resistance.
World of DTC Marketing
JULY 28, 2020
QUICK READ : Pharma had a chance to earn some goodwill with a very skeptical public but it’s become obvious that the rush to develop a vaccine is about profit, executive stock, and Wall Street despite potential huge investments from the government. Moderna, a 10-year-old vaccine developer based in Cambridge, Mass.,
pharmaphorum
DECEMBER 18, 2023
Collaborative partnerships between universities and pharmaceutical companies are crucial for advancing biomedical research and development (R&D) and creating groundbreaking medicines. Explore the benefits and significance of these alliances in this informative piece.
World of DTC Marketing
JULY 30, 2021
Pharma companies, for the most part, still rely on outside digital agencies for their online work. Here are some of the things I learned in working with digital agencies at pharma. Another area that a lot of agencies need to develop. 9ine: What is their process for developing branded content online?
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content